NCT01820117 Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation Status COMPLETED Phase N/A
NCT01793233 Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Status COMPLETED Phase N/A
NCT01764230 Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients Status COMPLETED Phase NA
NCT01760655 Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT01712490 A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE3
NCT01660776 BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology Status COMPLETED Phase N/A
NCT01657331 Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) Status COMPLETED Phase PHASE1/PHASE2
NCT01652261 Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) Status WITHDRAWN Phase PHASE3
NCT01634217 Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT01611298 Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR Status COMPLETED Phase NA
NCT01592370 An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01569204 Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01534078 Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01523847 A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) Status COMPLETED Phase PHASE2
NCT01468311 Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT01453504 Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2